We are live on ! Find out more
Calamos Advisors

Calamos Advisors Portfolio holdings

AUM $28.2B
1-Year Est. Return 21.78%
This Fund
S&P 500
This Quarter Est. Return
+8.11%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$20.6B
AUM Growth
+$1.37B
Cap. Flow
-$6.1B
Cap. Flow %
-29.59%
Top 10 Hldgs %
22.72%
Holding
1,035
New
97
Increased
87
Reduced
313
Closed
112

Sector Composition

Rank Sector Weight
1 Technology 18.31%
2 Healthcare 8.45%
3 Financials 7.73%
4 Consumer Discretionary 7.1%
5 Communication Services 5.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DEN
801
DELISTED
Denbury Inc.
DEN
-265,179
Closed -$26M
TRCA.WS
802
DELISTED
Twin Ridge Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
TRCA.WS
-83,333
Closed -$6.26K
FRBN
803
DELISTED
Forbion European Acquisition Corp. Class A Ordinary Shares
FRBN
-750,000
Closed -$8.24M
FRBNW
804
DELISTED
Forbion European Acquisition Corp. Warrants
FRBNW
-250,000
Closed -$138K
NFNT.WS
805
DELISTED
Infinite Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
NFNT.WS
-750,000
Closed -$30K
CXAC.WS
806
DELISTED
C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
CXAC.WS
-150,000
Closed -$5.57K
ACAQ.WS
807
DELISTED
Athena Consumer Acquisition Corp. Redeemable warrants included as part of the units, each whole warrant exercisable for one share of Class A common stock for $11.50 per share
ACAQ.WS
-150,000
Closed -$54K
RBT.WS
808
DELISTED
Rubicon Technologies, Inc. Warrants, each warrant is exercisable for 1/8th of a share of Class A Common Stock at an exercise price of $92.00r share
RBT.WS
-350,000
Closed -$5.6K
NATI
809
DELISTED
National Instruments Corp
NATI
-276,662
Closed -$16.5M
SAMAW
810
DELISTED
Schultze Special Purpose Acquisition Corp. II Warrant
SAMAW
-150,848
Closed -$754
BIOSW
811
DELISTED
BioPlus Acquisition Corp. Warrants
BIOSW
-500,000
Closed -$28K
FZT.WS
812
DELISTED
FAST Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share
FZT.WS
-10,000
Closed -$5K
LFACW
813
DELISTED
LF Capital Acquisition Corp. II Warrants
LFACW
-275,000
Closed -$1.02K
MPRAW
814
DELISTED
Mercato Partners Acquisition Corporation Warrant
MPRAW
-125,000
Closed -$26.3K
HZNP
815
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
-100,000
Closed -$11.6M
ATVI
816
DELISTED
Activision Blizzard
ATVI
-417,229
Closed -$39.1M
ACRO.WS
817
DELISTED
Acropolis Infrastructure Acquisition Corp Warrants
ACRO.WS
-205,467
Closed -$12.3K
BRD.WS
818
DELISTED
Beard Energy Transition Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
BRD.WS
-271,216
Closed -$8.14K
JUN.WS
819
DELISTED
Juniper II Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
JUN.WS
-175,000
Closed -$455

Similar funds

Calamos Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, Calamos Advisors held 1,035 positions worth $20.6B, up 7.1% from $19.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Calamos Advisors withdrew a net $6.1B in Q4 2023, closing 112 positions and reducing 313 holdings. Its most notable exit was The AES Corporation, an estimated $45.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Calamos Advisors opened a new position in Amedisys worth $23M.

  • Calamos Advisors's largest Q4 2023 buy was Amedisys: 242,110 shares worth $23M.
  • Calamos Advisors added most to Tesla in Q4 2023, an estimated $63.7M increase.
  • Calamos Advisors's biggest Q4 2023 reduction was Mercado Libre, cutting an estimated $39M.
  • Calamos Advisors fully exited The AES Corporation in Q4 2023, selling an estimated $45.2M.
  • Calamos Advisors's ten largest holdings make up 23% of its $20.6B portfolio in Q4 2023.
  • Calamos Advisors opened 97 new positions and closed 112 in Q4 2023.
  • Calamos Advisors's portfolio value rose 7.1% quarter-over-quarter to $20.6B.

Based on Calamos Advisors's 13F filing for Q4 2023, filed 31 Jan 2024.